# assay_catalog.yaml
version: 1.0
last_updated: 2025-10-07
maintainer: "CMD Bioinformatics Team"
header: "Assay catalog for precision sequencing-based analysis in cancer at SMD, Lund"
description: |
  Section of Molecular Medicine (SMD) provides sequencing-based assays to all medical specialties at Region Skåne.
  The purpose of this website it to give an overwide of the available next generation sequencing (NGS) assays for
  somatic alterations in cancer that are provided at SMD

layout:
  order: ["WGS", "WTS", "GenePanels"]

modalities:
  WGS:
    label: "Whole Genome Sequencing (WGS)"
    description: "WGS analysis for hematology and solid tumors (SNV, CNV, SV, fusions)."

    categories:
      hematology:
        catalog_id: "tumwgs-hema"
        label: "Hematology"
        # WGS heme is an assay *family*; leave ASP links empty or point to the family anchor if you have one.
        asp_id: "tumwgs-hema"                 # (ASP) if a specific WGS-HEMA ASP exists, set it here.
        aspc_ids:
          production: "tumwgs-hema:production"                 # (ASPC) env->id (e.g., production: "...") if you operate configs for WGS.
        input_material: ["DNA", "Fresh", "Fresh Frozen", 'Blood', 'Bone marrow', "Other Neoplastic Tissue"]
        tat: "21 days"
        sample_modes: ["Tumor-normal"]
        subheading: "Myeloid and lymphoid malignancies"
        description: |
          Open WGS analysis. When applicable the GMS-HEM, GMS-HEM-myeloid, or GMS-HEM-lymphoid gene list is used for
          filtering SNV/INDEL. The GMS-HEM gene list and the Hematology Add-on gene list are used for filtering CNV
          and the Mitelman database is used for filtering fusion genes.
        gene_lists:                  # (ISGL) fetch by _id
          - key: "hematology_myeloid"   # ISGL _id
            label: "GMS-HEM (myeloid)"
            description: "Gene list for myeloid malignancies"
          - key: "hematology_lymphoid"
            label: "GMS-HEM (lymphoid)"
            description: "Gene list for lymphoid malignancies"
          - key: "hematology_addons"
            label: "Hematology Add-Ons"
            description: "A complement gene list used for filtering CNV in WGS hematology analysis."

      solid_tumors:
        catalog_id: "tumwgs-solid"
        label: "Solid tumors"
        asp_id: "tumwgs-solid"                 # (ASP) if a specific WGS-SOLID ASP exists, set it here.
        aspc_ids:
          production: "tumwgs-solid:production"                 # (ASPC) env->id (e.g., production: "...") if you operate configs for WGS.
        input_material: ["DNA", "Fresh", "Fresh Frozen", "Neoplastic Tissue"]
        tat: "14-21 days"
        sample_modes: ["Tumor-normal"]
        description: |
          Open WGS analysis. When applicable the GMS Pediatric Cancer gene list is used for filtering SNV/INDEL.
          The GMS Pediatric Cancer gene list is used for filtering CNV and the X is used for filtering fusion genes.
        subheading: "Solid tumors in pediatric cancer"
        gene_lists:
          - key: "solid_GMSv3" # ISGL _id
            label: "GMS-ST"
            description: "Solid tumors in pediatric cancer"

      drug_addon:
        catalog_id: "drug-addon"
        label: "Drug Add-on"
        asp_id: "drug-addon"                 # (ASP) if a specific WGS-Drug-Add-on ASP exists, set it here.
        aspc_ids:
          production: "drug-addon:production"                 # (ASPC) env->id (e.g., production: "...") if you operate configs for WGS.
        input_material: ["NA"]
        tat: "NA"
        sample_modes: ["NA"]
        description: A complement gene list for drug targets used in WGS analysis according to https://www.oncokb.org/actionable-genes#sections=Tx
        subheading: ""
        gene_lists:
          - key: "drug_addon" # ISGL _id
            label: "Drug Add-on"
            description: "A complement gene list for drug targets used in WGS analysis according to https://www.oncokb.org/actionable-genes#sections=Tx"

  WTS:
    label: "Whole Transcriptome Sequencing (WTS)"
    description: "Open transcriptome analysis; no fixed genelist applied yet."

    categories:
      combined:
        catalog_id: "wts-combined"
        label: "Hematology & solid tumors"
        asp_id: "fusion"
        aspc_ids:
          production: "fusion:production"
        input_material: ["RNA", "Fresh", "Fresh Frozen", "Blood", "Bone marrow", "Other Neoplastic Tissue"]
        tat: "7-14 days"
        sample_modes: ["Tumor-only"]
        description: "Open RNA-seq analysis for gene fusion detection"
        subheading: "Hematology & solid tumors"
        gene_lists: []               # intentionally empty

  GenePanels:
    label: "Targeted Gene Panels"
    description: "Curated NGS panels for specific tumor or disease types."

    categories:
      hematology:
        catalog_id: "hema_GMSv1"
        label: "GMS-HEM"
        # Link to the real assay + configs you showed in ASP/ASPC examples:
        asp_id: "hema_GMSv1"                   # (ASP)
        aspc_ids:                                  # (ASPC) env → _id
          production: "hema_GMSv1:production"
        input_material: ["DNA", "Fresh", "Fresh Frozen", "Blood", "Bone marrow", "Other Neoplastic Tissue"]
        tat: "21 days"
        sample_modes: ["Tumor-only"]
        description: "Open analysis. Also, single gene analysis e.g. CXCR4, KIT, MYD88, KIT, UBA1 is available (select from GMS-HEM)"
        subheading: ""
        gene_lists:
          - key: "hema_GMSv1"               # (ISGL) Key must match ISGL _id
            label: "GMS-HEM"
            description: "Gene list for hematologic malignancies"
          - key: "hematology_myeloid"             # (ISGL)
            label: "H-MGP"
            description: "Gene list for myeloid malignancies" # Text above the table
          - key: "hematology_lymphoid"
            label: "H-LGP"
            description: "Gene list for lymphoid malignancies"
          - key: "mpn"
            label: "MPN"
            description: "Gene list for myeloproliferative neoplasms"
            tat: "7-10 days" # Will have priority over the general TAT if defined
          - key: "kll"
            label: "KLL"
            description: "Gene list for chronic lymphocytic leukemia"
            tat: "7-10 days"
          - key: "hemsnabb"
            label: "Hem-Snabb"
            description: "Limited gene list for acute myeloid leukemia (AML)"
            tat: "7-10 days"
            analysis: ["SNV", "Preliminary CNV"]  # Override analysis types if needed
          - key: "single_gene"
            label: "Single Gene"
            description: "Single gene analysis"
            tat: "7-10 days"

      solid_tumors:
        catalog_id: "solid_GMSv3"
        label: "GMS-ST"
        asp_id: "solid_GMSv3"                      # (ASP) if this is your panel’s ASP _id
        aspc_ids:
          production: "solid_GMSv3:production"     # (ASPC)
        input_material: ["DNA", "FFPE", "Fresh", "Fresh Frozen", "Neoplastic Tissue"]
        tat: "NA"
        sample_modes: ["Tumor-normal"]
        description: "Gene list for solid tumors including x drug targets according to https://www.oncokb.org/actionable-genes#sections=Tx"
        subheading: ""
        gene_lists:
          - key: "solid_GMSv3"               # (ISGL) Key must match ISGL _id
            label: "GMS-ST"
            description: "Gene list for solid tumors"
          - key: "endometrial"                  # (ISGL) Key must match ISGL _id
            label: "Endometrial cancer"
            description: "Gene list for endometrial cancer"
            tat: "21 days"
            input_material: ["DNA", "FFPE", "Neoplastic Tissue"]
          - key: "colon"
            label: "CRC"
            description: "Gene list for colorectal cancer (CRC)"
            tat: "14 days"
            input_material: ["DNA", "FFPE", "Neoplastic Tissue"]
          - key: "drug_targets"
            label: "Drug Targets"
            description: "Gene list for a limited number of actionable genes included in the GMS-ST panel according to https://www.oncokb.org/actionable-genes#sections=Tx. For a full list please use the WGS assay or GMS-ST (tumor/normal) assay."
            tat: "14 days"
            input_material: ["DNA", "FFPE", "Neoplastic Tissue"]

      solid_tumors_rna:
        catalog_id: "solidRNA_GMSv5"
        label: "GMS-ST RNA"
        asp_id: "solidRNA_GMSv5"                   # (ASP) if you version RNA separately
        aspc_ids:
          production: "solidRNA_GMSv5:production"  # (ASPC)
        input_material: ["RNA", "FFPE", "Neoplastic Tissue"]
        tat: "21 days"
        sample_modes: ["Tumor-only"]
        description: "Gene fusion panel for x selected genes in solid tumors"
        subheading: ""
        gene_lists: []                              # leave empty unless you bind ISGLs

      rna_fusion:
        catalog_id: "rna-fusion"
        label: "RNA Fusion Panel"
        asp_id: "RNA-fusion"                       # (ASP) if you keep a generic fusion panel
        aspc_ids:
          production: "RNA-fusion:production"
        input_material: ["RNA", "FFPE", "Neoplastic Tissue"]
        tat: "14 days"
        sample_modes: ["Tumor-only"]
        description: "Gene fusion panel for 160 selected genes in solid tumors"
        subheading: ""
        gene_lists: []
